Studies on the biosynthesis of avermectins.
To elucidate the pathway of avermectin biosynthesis, the biosynthetic relationships of avermectins A1a, A2a, B1a, B2a, and their respective monosaccharides and aglycones were studied. 14C-labeled avermectin compounds prepared from [1-14C]acetate were fed to Streptomyces avermitilis strain MA5502 and their metabolites were determined. Two furan ring-free aglycones, 6,8a-seco-6,8a-deoxy-5-keto avermectin B1a and B2a, have been isolated from the fermentation broth of a blocked mutant of S. avermitilis. Addition of the compounds and a semisynthetic compound, 5-keto avermectin B2a aglycone, to the fermentation medium of a second blocked mutant established that the two compounds are intermediates in the avermectin biosynthetic pathway immediately preceding avermectin aglycones.
Chen
T S
TS
Department of Fermentation Microbiology, Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065.
Inamine
E S
ES
D000085:Acetates / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D005285:Fermentation; D007559:Ivermectin / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000235:genetics; D009154:Mutation; D013302:Streptomyces / Q000235:genetics / Q000378:metabolism*
D000085:Acetates; D007559:Ivermectin; C019264:avermectin